INMED PHARMACEUTICALS INC. (INM) Shareholders’ equity 2021–2025
INMED PHARMACEUTICALS INC. (INM) shareholders’ equity at each fiscal year-end, per SEC filings.
$13.4MFY2025 · since FY2021: $7.4M → $13.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.4M | +45.9% |
| FY2024 | $9.2M | -23.9% |
| FY2023 | $12.1M | +33.2% |
| FY2022 | $9.1M | +23.1% |
| FY2021 | $7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice